IMMIX BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $539.6K
Liabilities Breakdown FY2020
Total Liabilities: $5.3M
Asset Breakdown
Total Assets: $539.6K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $391.1K | 72.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.4K | 1.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $141.2K | 26.2% |
Liabilities Breakdown
Total Liabilities: $5.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.3M | 100.0% |